bevacizumab,trifluridine tipiracil
roche,otsuka,taiho pharma
[]
more practice confirming than practice changing and very reassuring to see. tas-102 + bev better than tas-102 alone for refractory mcrc. both os and pfs significantly improved and clinically relevant. #gi23 
🇮🇸Medical Oncologist/Educator, NET/GI/CUP enthusiast. Husband/dadx4 (bad dad jokes). Cyclist. Avant gardener. Professor of Oncology, Mayo Clinic. Tweets mine.